Most cortisol-producing adenomas with overt Cushing’s syndrome are associated with mutations in the cAMP/PKA pathway (PRKACA and GNAS), which are less frequency detected in patients with PACS or ACS (23–27). This evidence concerns the gene PRKACA and Cushing syndrome due to macronodular adrenal hyperplasia.